4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-029879
EVP, Research & CSO sold 3,805 shares at $30.07 ($114,418)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-14 | Exercise or conversion : show line 1 in the form | +3,805 | $1.53 | $5,822 | 3,805 | D |
| 2020-05-14 | Sale : show line 2 in the form | −3,805 | $30.07 | $114,418 | 0 | D |
| Open-market sales · 3,805 sh · avg $30.07 · $114,418 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-14 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −3,805 | 551,750 | D |
Loading xslF345X03/doc4.xml…